Candida albicans is the number one cause of life-threatening fungal infections in hospitals. A key virulence attribute of C. albicans is the ability to switch between multiple distinct cellular forms that are adapted to unique environmental niches. The white-opaque phenotypic switch in C. albicans generates two distinct pathogenic cell types from a single genome, and each cell type is heritably maintained for hundreds of generations without any change in the underlying genomic sequence. Although heritable transcriptional programs underlie critical cell-fate decisions in organisms ranging from unicellular prokaryotes through multicellular higher eukaryotes, the underlying logic of these complex transcriptional circuits remains largely uncharacterized. The white-opaque switch has emerged as a powerful model system for understanding the transcriptional regulation of heritable cell-fate decisions in eukaryotes. Equivalent programs are not found in other model yeasts, like S. cerevisiae, making C. albicans an attractive ?simple? eukaryotic organism to study how cellular memory is regulated and inherited from one generation to the next. Many of the key transcriptional regulators have been identified, and the structures of the transcriptional networks that control switching have been elucidated. The high-dimensional interwoven structure of the opaque-specific regulatory circuit bears striking similarities to heritable transcriptional networks in higher eukaryotes, yet due to the complexity of these circuits, their logic remains elusive. This proposal seeks to uncover the logic of the transcriptional regulatory circuits that control heritable differentiation between the white and opaque cell types.
Aim 1 : Develop and validate a quantitative high-throughput assay for C. albicans white-opaque phenotypic switching. Using engineered fluorescent reporter strains and semi-automated flow cytometry, we will develop a high-throughput quantitative white-opaque switching assay. This assay will be verified for accuracy and robustness by analyzing a panel of previously-characterized switch regulatory mutants in a side- by-side comparison between our newly-developed assay and the traditional colony-plating assay.
Aim 2 : Determine the logic of the transcriptional circuits that control white and opaque cell-type heritability. Using CRISPR-mediated genome editing and high-throughput switch frequency analysis, we will systematically disrupt specific transcriptional regulatory interactions within the white and opaque transcriptional circuits and measure the resulting effects on switch dynamics. This data will be used to identify regulatory interactions that are critical for heritability and to model the logic of the white-opaque switch circuits. The completion of these aims will reveal the logic of the transcriptional circuits that control heritable cell-type differentiation in C. albicans. This work will also provide a paradigm for investigating heritable transcriptional circuits that control cell-fate decisions in higher eukaryotes.

Public Health Relevance

Candida albicans is the most common fungal pathogen of humans, causing debilitating and life-threatening infections, especially in immunocompromised individuals. This proposal seeks to develop novel approaches and assays to enable rapid dissection and analysis of the transcriptional regulatory circuits that control a form of heritable cell-type differentiation, called the white-opaque switch, that generates two distinct pathogenic cell types in C. albicans. These innovative methodologies will lead to a detailed understanding of the logic of the white-opaque switch, will reveal critical regulatory connections that are responsible for the heritability, robustness, environmental responsiveness, and stochasticity of this switch, and will yield insights into the dynamics of similar high-dimensional regulatory circuits that control critical cell-fate decisions in higher eukaryotes, such as the maintenance of stem-cell pluripotency.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15AI137975-01A1
Application #
9656755
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Love, Dona
Project Start
2018-12-11
Project End
2021-11-30
Budget Start
2018-12-11
Budget End
2021-11-30
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Merced
Department
Biochemistry
Type
Earth Sciences/Resources
DUNS #
113645084
City
Merced
State
CA
Country
United States
Zip Code
95343